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Abstract. Celiac disease (CD) is an autoimmune disorder provoked by the wheat gluten and related proteins from 
other grains. The only treatment for the patients is a lifelong gluten free diet (GFD). Oxidative stress has been 
implicated in the pathogenesis of CD. The aim of this study was to examine the modulation of the biochemical 
response to oxidative stress in children affected by CD. The study involved peripheral blood samples and small 
intestinal biopsies from 69 children diagnosed with CD. According to the histological findings, patients were divided 
into following groups: Marsh 0: normal mucosa with no signs of inflammation (n=31); Marsh 1: mucosa was 
characterized by intraepithelial lymphocytosis (n=5); Marsh 2: intraepithelial lymphocytosis was accompanied by 
crypt hyperplasia (n=4); Marsh 3a: mucosa showed partial villous atrophy (n=20); Marsh 3b: subtotal villous 
atrophy was present (n=9). For the statistical purposes groups Marsh 1 and Marsh 2 were treated as one (Marsh 1+2, 
n=9). The activities and protein levels of copper, zinc superoxide dismutase (CuZnSOD) and manganese SOD 
(MnSOD), as well as the concentrations of lipid hydroperoxides (LOOH) were determined in intestinal biopsies, while 
in the peripheral blood, MnSOD activity was not measured, due to the methodological obstacles. CuZnSOD activity in 
the blood varied significantly between the analyzed groups. Marsh 3a and Marsh 3b had increased CuZnSOD activity 
comparing to the Marsh 0 (P < 0.05). LOOH concentration also varied significantly. LOOH level was higher in the 
blood of Marsh 3a (P < 0.001) and Marsh 3b (P < 0.05), than in Marsh 0. In the biopsy samples, MnSOD activity and 
LOOH concentration showed significant differences between the groups, while no significant difference was found for 
CuZnSOD activity. In comparison to Marsh 0, MnSOD activity was significantly elevated in Marsh 3a (P < 0.01). 
Significant increase in LOOH concentration was found in Marsh 3a (P < 0.001) and Marsh 3b (P < 0.01), comparing 
to Marsh 0. In addition, Marsh 3a group had higher LOOH concentration than Marsh 1+2. Relative MnSOD and 
CuZnSOD protein level in the peripheral blood and intestinal mucosa did not vary significantly between the analyzed 
groups. Positive correlations were found between the severity of mucosal lesion and CuZnSOD activity (P < 0.001), as 
well as LOOH concentration (P < 0.001) in the peripheral blood. Similar correlations were found also in intestinal 
mucosa: MnSOD: P < 0.05; CuZnSOD: P < 0.05; LOOH: P < 0.001. Our results show that oxidant/antioxidant 
balance is disturbed in CD patients with mucosal lesions. An increase in SOD activity as a consequence of oxidant 
pressure is not enough to maintain the normal level of free radicals, which leads to enhanced lipid peroxidation. 
These processes persist even in some patients on a long-term GFD. 
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1. INTRODUCTION 
Reactive oxygen species (ROS) are generated as by-
products of metabolic processes in cells. In the 
physiological conditions the level of ROS is kept in 
check by an array of antioxidant (AO) enzymes 
(superoxide dismutase (SOD), catalase (CAT), 
glutathione peroxidase (GPx), glutathione reductase 
(GR)), as well as non-enzymatic antioxidants (vitamins 
C, E, A, glutathione). If the production of ROS 
overwhelms the AO capacity of the cell, oxidative stress 
occurs. One of the first consequences of the oxidative 
stress is the oxidation of membrane lipids, a chain 
reaction known as lipid peroxidation which causes a 
loss of the membrane fluidity, disrupts membrane 
integrity and functions. 
Celiac disease (CD) is an autoimmune disorder 
provoked by wheat gluten and related proteins from 
some other grains (barley or rye). In genetically 
predisposed individuals, gluten activates the immune 
cascade which leads to the inflammation of intestinal 
mucosa. The clinical presentation of CD is extremely 
heterogeneous [1], ranging from the asymptomatic 
cases to severe malabsorption of micro- and 
macronutrients, with a variety of conditions, including 
diarrhoea, constipation, flatulence, weight loss, vitamin 
and mineral deficiencies, iron deficiency anaemia and 
bone disease [2]. 
CD is one of few disorders for which a specific diet 
is the only treatment. Persons affected by CD must 
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adhere to a lifelong strict gluten-free diet, which 
usually allows the intestinal mucosa to heal, resolves 
gastrointestinal symptoms and prevents the 
complications that may occur if the disease remains 
untreated. 
Previous data [3, 4] revealed that oxidative stress 
and ROS play an important role in the pathogenesis of 
CD. Our former investigations demonstrated that the 
antioxidant defense system is notably disturbed in the 
blood and intestinal mucosa of patients with CD [5, 6]. 
The aim of this study was to investigate alterations in 
SOD activity and protein levels, as well as the level of 
lipid peroxidation in blood and intestinal mucosa of 
pediatric CD patients. 
2. MATERIALS AND METHODS 
2.1. Subjects 
The study involved peripheral blood samples and 
small intestinal biopsies from 69 children with celiac 
disease (32 boys, 37 girls; median age 8 years; range 
1.5-16 years) who were attended at the Children's 
Hospital, Clinical Center of Serbia, Belgrade, Serbia for 
gastroenterological issues. The Ethical Committee of 
the Faculty of Medicine, University of Belgrade, 
approved the study. The blood samples were collected 
on the day of the intestinal biopsy. In 40 children the 
diagnosis was made in early childhood and by the time 
of sampling, they had been subjected to gluten-free diet 
(GFD) for 2-4 years. The remaining 29 children were 
diagnosed at the time of the study and were using the 
gluten containing diet. The diagnosis of celiac disease 
was based on the revised criteria of the European 
Society for Paediatric Gastroenterology, Hepatology 
and Nutrition [7]. Typical villous atrophy was found on 
the examination of intestinal biopsy specimens in all 
children on gluten containing diet.  
Histological classification was performed according 
to the modified Oberhuber-Marsh model [8]. Patients 
were divided into following groups: Marsh 0: normal 
mucosa with no signs of inflammation (n = 31, all on 
GFD); Marsh 1: mucosa was characterized by 
intraepithelial lymphocytosis (n = 5, all on GFD); 
Marsh 2: intraepithelial lymphocytosis was 
accompanied by crypt hyperplasia (n = 4, all on GFD); 
Marsh 3a: mucosa showed partial villous atrophy (n = 
20, all newly diagnosed and using gluten containing 
diet); Marsh 3b: subtotal villous atrophy was present (n 
= 9, all newly diagnosed and using gluten containing 
diet). For the statistical purposes groups Marsh 1 and 
Marsh 2 were treated as one (Marsh 1+2, n = 9). 
2.2 Sample preparation 
From each patient, 6-8 proximal small intestinal 
biopsy specimens were obtained. Some of them were 
used for the histopathological analysis and others were 
washed in ice-cold saline and frozen at -70 °C for SOD 
and LOOH assays. Samples were thawed within a week 
and homogenized in 20 volumes of cold sucrose buffer 
pH 7.4. Homogenates were vortexed 3 times for 15 
seconds and then kept at -70 °C. Thawed homogenates 
were centrifuged (Eppendorf centrifuge 5417R, 
Eppendorf-Netheler-Hinz GmbH, Hamburg, Germany) 
at 8600 g, 4 °C, for 10 minutes. Supernatants were 
stored at -70 °C. 
On the day of the biopsy, peripheral blood samples 
were collected in tubes containing lithium heparin as 
anticoagulant. The blood was centrifuged at 2500 g, 4 
°C for 5 minutes (Eppendorf centrifuge 5417, 
Eppendorf AG, Hamburg, Germany) to separate the 
plasma. The plasma was stored at -70 °C for the lipid 
hydroperoxides (LOOH) assay and the buffy coat was 
discarded. The red blood cells were drawn from the 
bottom, washed three times in cold saline and 
haemolysed by adding four packed-cell volumes of ice-
cold demineralised ultra pure water (MilliQ reagent 
grade water system, Millipore Corp., Bedford, MA, 
USA). Ethanol-chloroform (5/3 vol/vol) extraction was 
performed to remove haemoglobin interference. 
Extracts were stored at -70 °C for later analysis. 
2.3. Assays 
All assays were performed spectrophotometrically 
(Perkin Elmer Spectrophotometer, Lambda 25, Perkin 
Elmer Instruments, Norwalk, CT, USA). 
The SOD specific enzyme activities in blood were 
expressed as units per gram of haemoglobin (U/g Hb) 
and in tissue homogenates as units per milligram of 
protein (U/mg). Concentrations of LOOH were 
expressed in mol/L. 
SOD assay. SOD activity was measured using the 
Oxis Bioxytech® SOD-525TM Assay (Oxis 
International, Inc., Portland, OR, USA). The kinetic 
measurement of the change in absorbance at 525 nm is 
performed. One SOD-525 activity unit is defined as the 
activity that doubles the autoxidation rate of the 
control blank. In blood lysates only CuZnSOD activity 
was measured, since ethanol-chloroform extraction 
reagent, necessary for removing the haemoglobin 
interference, inactivates MnSOD. In tissue 
homogenates, the total SOD activity is determined as 
described above. Then, CuZnSOD activity was 
measured in the same manner, after pretreating 
samples with ethanol-chloroform reagent. MnSOD 
activity was then calculated by subtracting CuZnSOD 
activity from the total SOD activity.  
LOOH assay. The concentration of LOOH was 
determined by the Oxis Bioxytech® LPO560™ Assay 
(Oxis International, Inc., Portland, OR, USA). The 
assay is based on the oxidation of ferrous to ferric ions 
by LOOH from the sample under acidic conditions. The 
absorbance at 560 nm is directly proportional to the 
LOOH concentration.  
Western blotting. Equal amounts of the protein 
were dissolved in SDS-PAGE sample loading buffer and 
electrophoresed in polyacrylamide gel (10%), according 
to Laemmli (1970). For Western blotting, the proteins 
were transferred to nitrocellulose membranes. Non-
specific binding sites on the membranes were blocked 
with TBST (10 mM Tris, 150mMNaCl, 0.1% Tween 20) 
containing 1% BSA and then probed with rabbit anti-
CuZnSOD polyclonal antibody (SOD-100, Stressgen 
Biotechnologies; 1:7500). After the blots were washed, 
alkaline phosphatase-conjugated goat anti-rabbit IgG 
(SAB-301, Stressgen Biotechnologies; 1:7500) was 
added. Each blot was triplicated and scanned. The 
density of bands was determined by ImageJ processing 
software and normalized to the loading control. 
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2.4. Statistical analysis 
The differences between the groups were tested 
using the analysis of variance (ANOVA) in the blood 
samples and the Kruskal-Wallis test in tissue 
homogenates, whereas the significances were evaluated 
by the Tukey or the Mann-Whitney test in the blood 
and tissue homogenates, respectively. The Spearman 
rank-order correlation coefficient was used to 
investigate the associations between the analyzed 
parameters and histological lesions. Two-tailed  
p values are given throughout. 
3. RESULTS 
 
Figure 1. CuZnSOD activity (U/gHb) and LOOH 
concentration (mol/L) in peripheral blood of celiac disease 
patients. *** P < 0.001, * P < 0.05, significantly different 
from Marsh 0 group. 
The enzyme activity of CuZnSOD and LOOH 
concentration in the peripheral blood are shown in  
Fig. 1. CuZnSOD activity varied significantly between 
the analyzed groups (F3,65 = 4.51, P < 0.01). Both 
groups with villous atrophy had increased CuZnSOD 
activity comparing to the Marsh 0 group (P < 0.05). 
LOOH concentration also varied significantly between 
the analyzed groups (F3,65 = 11.43, P < 0.001). In the 
blood of patients with partial and subtotal villous 
atrophy LOOH level was ~ 45 % (P < 0.001) and  
~ 30 % higher (P < 0.05) respectively, than in patients 
with normal mucosa.  
 
Figure 2. MnSOD andCuZnSOD activity (U/gHb) and LOOH 
concentration (mol/L) in the intestinal mucosa of celiac 
disease patients. *** P < 0.001, ** P < 0.01, significantly 
different from Marsh 0 group. # P < 0.05, significantly 
different from Marsh 1+2 group 
The activities of both SODs, as well as the 
concentration of LOOH in the intestinal mucosa are 
represented in Fig. 2. MnSOD activity and LOOH 
concentration showed significant differences between 
the groups: MnSOD: H = 8.79, P < 0.05;  
LOOH: H = 22.92, P < 0.001, while no significant 
difference between the patient groups was found for 
CuZnSOD activity (H = 5.23, P > 0.05). In comparison 
to the patients with normal mucosa, MnSOD activity 
was significantly elevated in Marsh 3a group  
(P < 0.01). Significant increase in LOOH concentration 
was found in both groups with villous atrophy (Marsh 
3a: P < 0.001; Marsh 3b: P < 0.01), comparing to 
Marsh 0. In addition, the patients in Marsh 3a group 
had higher LOOH concentration than the patients in 
Marsh 1+2 group. 
Relative MnSOD and CuZnSOD protein level in the 
peripheral blood and intestinal mucosa did not vary 
significantly between the analyzed groups (Figs. 3  
and 4). 
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Figure 3. Relative CuZnSOD protein level in peripheral blood 
of celiac disease patients 
 
Figure 4. Relative MnSOD and CuZnSOD protein level in the 
intestinal mucosa of celiac disease patients 
Positive correlations were found between the 
severity of mucosal lesion and CuZnSOD activity  
(rs = 0.39, P < 0.001), as well as LOOH concentration 
(rs = 0.52, P < 0.001) in the peripheral blood (Fig. 5). 
Similar correlations were found also in intestinal 
mucosa: MnSOD: rs = 0.27, P < 0.05;  
CuZnSOD: rs = 0.28, P < 0.05; LOOH: rs = 0.55,  
P < 0.001 (Fig. 6). 
 
Figure 5. Data plot and coefficients of Spearman’s correlation 
rs between CuZnSOD activity and LOOH concentration and 
the severity of mucosal lesion in the peripheral blood of 
pediatric patients with celiac disease.  
 
Figure 6. Data plot and coefficients of Spearman’s correlation 
rs between MnSOD and CuZnSOD activity and LOOH 
concentration and the severity of mucosal lesion in the 
intestinal mucosa of pediatric patients with celiac disease.  
4. DISCUSSION 
It is well known that free radicals and other ROS 
are constantly produced in all cells as the by-products 
of normal cellular metabolism and may play an 
important role in the pathogenesis of various disorders 
[9]. Deleterious effects of ROS are counteracted by AO 
defense system. Superoxide anion radical is the 
product of the one-electron reduction of oxygen O2, 
which occurs widely in nature [10] and superoxide 
dismutases that act as its scavengers are considered to 
be the first line of AO defense.  
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In our study CuZnSOD activity was increased in the 
blood of patients with partial or subtotal villous 
atrophy, while SOD protein levels remained stable in 
comparison to subjects with healthy mucosa. The level 
of LOOH was also elevated in the blood of the same 
patient groups. The increase in the SOD activity 
probably represents a physiological response to the 
increased pro-oxidant pressure in CD patients. 
Namely, previous reports have shown that, in CD 
patients, gluten activates pro-oxidant processes that 
result in an overproduction of free radicals [11]. In spite 
of higher SOD activity, the elevated plasma 
concentrations of LOOH (over 30%) found in our 
study, indicate that AO protection is not adequate in 
patients with more pronounced mucosal lesions. 
Similar alterations were also found in the intestinal 
mucosa. Both SOD activities were increased in the 
patients with villous atrophy, although the increase 
was significant only for MnSOD. These changes of SOD 
activities, as a response to the increased rate of ROS 
production, were not caused by the changes in relative 
protein levels of these enzymes, which were found to be 
similar in all patient groups. Most probably, the 
elevation of the SOD activities is a consequence of the 
posttranslational chemical modification of these 
enzymes under the changed redox environment [12, 
13].  
Besides the increased SOD activities, LOOH 
concentrations were also elevated in the patients with 
partial or subtotal villous atrophy, not only comparing 
to the patients with healthy mucosa, but also to those 
with milder mucosal lesion. The intestinal mucosa is 
continuously exposed to numerous oxidants, mutagens 
and carcinogens from diet, as well as to endogenous 
ROS. In the healthy mucosa, several defense 
mechanisms are employed to preserve the cell integrity 
and tissue homeostasis: the intestine is able to 
maintain high concentrations of antioxidants and to 
up-regulate antioxidant enzymes, while apoptosis is 
induced in spent or damaged enterocytes [14]. Our 
data show that in untreated CD patients AO defense 
system is not capable of maintaining the redox balance, 
which results in increased lipid peroxidatin and 
probably oxidative damage of other biomolecules. 
Elevated LOOH may contribute to the disruption of 
intestinal detoxifying pathways and to disfunction of 
enterocytes, leading to various disorders of digestive 
tract. Our findings are in accordance with the results of 
Rivabene et al. [15] who found elevated LOOH in the 
cell culture after treating the cells with gliadin 
peptides. Important results of our study are strong 
correlations between the analyzed parameters and the 
histological findings. Namely, both SOD activities, as 
well as LOOH levels significantly positively correlated 
with the severity of mucosal lesion, pointing to an 
important role of the oxidative stress and AO defense 
system in the pathogenesis of CD. We suggest that AO 
parameters should be involved in the analysis, 
prediction and follow-up of histological changes in 
patients affected by CD. 
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